新冠病毒COVID-19-话题@MedSci - 梅斯（MedSci）

#新冠病毒COVID-19#

26篇内容 | 1966人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1851022, encodeId=d4f3185102286, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, objectTitle=FDA批准新冠病毒COVID-19的快速检测试剂盒--45分即可确认是否感染, objectType=article, longId=190792, objectId=e405190e9221, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e405190e9221, replyNumber=0, likeNumber=77, createdTime=2020-04-03, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e405190e9221, moduleTitle=FDA批准新冠病毒COVID-19的快速检测试剂盒--45分即可确认是否感染, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e405190e9221)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1851036, encodeId=9de11851036ae, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, objectTitle=双抗体鸡尾酒疗法REGN-COV2：再生元启动针对新冠病毒COVID-19的首项临床研究, objectType=article, longId=195726, objectId=ad9f195e2630, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad9f195e2630, replyNumber=0, likeNumber=61, createdTime=2020-10-08, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad9f195e2630, moduleTitle=双抗体鸡尾酒疗法REGN-COV2：再生元启动针对新冠病毒COVID-19的首项临床研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ad9f195e2630)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1851031, encodeId=336f185103130, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, objectTitle=Alnylam/Vir宣布推进RNAi疗法VIR-2703，用于抵抗新冠病毒COVID-19, objectType=article, longId=193613, objectId=b78f193613fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b78f193613fa, replyNumber=0, likeNumber=79, createdTime=2021-02-23, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b78f193613fa, moduleTitle=Alnylam/Vir宣布推进RNAi疗法VIR-2703，用于抵抗新冠病毒COVID-19, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b78f193613fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1851025, encodeId=a6a8185102503, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, objectTitle=EMA建议新冠病毒COVID-19感染的高血压患者，继续服用血管紧张素转化酶抑制剂, objectType=article, longId=191243, objectId=8009191243cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8009191243cd, replyNumber=0, likeNumber=53, createdTime=2020-06-30, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8009191243cd, moduleTitle=EMA建议新冠病毒COVID-19感染的高血压患者，继续服用血管紧张素转化酶抑制剂, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8009191243cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1851030, encodeId=dff31851030cd, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, objectTitle=临床研究证实：羟氯喹治疗新冠病毒COVID-19感染患者无益处且死亡率更高, objectType=article, longId=192737, objectId=3029192e3711, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3029192e3711, replyNumber=0, likeNumber=79, createdTime=2020-05-24, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3029192e3711, moduleTitle=临床研究证实：羟氯喹治疗新冠病毒COVID-19感染患者无益处且死亡率更高, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3029192e3711)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1851023, encodeId=7158185102358, content=<a href='/topic/show?id=0406580667c' target=_blank style='color:#2F92EE;'>#新冠病毒COVID-19#</a>, objectTitle=日本的干细胞疗法HLCM051，正在开发用于新冠病毒COVID-19感染引起的急性呼吸窘迫综合症, objectType=article, longId=190932, objectId=f0e41909325f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0e41909325f, replyNumber=0, likeNumber=0, createdTime=2020-10-30, rootId=0, userName=yyanpro@21cn.c, userId=f00658, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0e41909325f, moduleTitle=日本的干细胞疗法HLCM051，正在开发用于新冠病毒COVID-19感染引起的急性呼吸窘迫综合症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f0e41909325f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

新冠病毒COVID-19

2020-05-29

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#新冠病毒COVID-19#

FDA批准新冠病毒COVID-19的快速检测试剂盒--45分即可确认是否感染

2020-04-03

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#新冠病毒COVID-19#

双抗体鸡尾酒疗法REGN-COV2：再生元启动针对新冠病毒COVID-19的首项临床研究

2020-10-08

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#新冠病毒COVID-19#

Alnylam/Vir宣布推进RNAi疗法VIR-2703，用于抵抗新冠病毒COVID-19

2021-02-23

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#新冠病毒COVID-19#

EMA建议新冠病毒COVID-19感染的高血压患者，继续服用血管紧张素转化酶抑制剂

2020-06-30

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#新冠病毒COVID-19#

临床研究证实：羟氯喹治疗新冠病毒COVID-19感染患者无益处且死亡率更高

2020-05-24

yyanpro@21cn.c (审核中...)

前往app查看评论内容

#新冠病毒COVID-19#

日本的干细胞疗法HLCM051，正在开发用于新冠病毒COVID-19感染引起的急性呼吸窘迫综合症

2020-10-30

科室
- - 订阅+
  - 更多科室
工具
服务